| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | migracytosis | 1.97e-06 | 8 | 6 | 2 | GO:0140495 | |
| GeneOntologyBiologicalProcess | mitocytosis | 1.97e-06 | 8 | 6 | 2 | GO:0160040 | |
| GeneOntologyBiologicalProcess | mitochondrion distribution | 2.47e-05 | 27 | 6 | 2 | GO:0048311 | |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization | 5.20e-05 | 39 | 6 | 2 | GO:0051654 | |
| GeneOntologyBiologicalProcess | mitochondrion localization | 1.37e-04 | 63 | 6 | 2 | GO:0051646 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane potential | 3.45e-04 | 100 | 6 | 2 | GO:0051881 | |
| GeneOntologyCellularComponent | migrasome | 2.47e-06 | 9 | 6 | 2 | GO:0140494 | |
| GeneOntologyCellularComponent | focal adhesion | 6.02e-03 | 431 | 6 | 2 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 6.35e-03 | 443 | 6 | 2 | GO:0030055 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.36e-02 | 658 | 6 | 2 | GO:0030312 | |
| Domain | Tetraspanin_CS | 1.80e-05 | 21 | 6 | 2 | IPR018503 | |
| Domain | TM4_1 | 2.79e-05 | 26 | 6 | 2 | PS00421 | |
| Domain | Tetraspanin | 4.25e-05 | 32 | 6 | 2 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 4.25e-05 | 32 | 6 | 2 | IPR008952 | |
| Domain | Tetraspanin/Peripherin | 4.52e-05 | 33 | 6 | 2 | IPR018499 | |
| Domain | Tetraspannin | 4.52e-05 | 33 | 6 | 2 | PF00335 | |
| Domain | - | 1.72e-02 | 663 | 6 | 2 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.93e-02 | 706 | 6 | 2 | IPR013783 | |
| Pubmed | Mitocytosis, a migrasome-mediated mitochondrial quality-control process. | 1.12e-06 | 10 | 6 | 2 | 34048705 | |
| Pubmed | Appearance of new tetraspanin genes during vertebrate evolution. | 4.71e-06 | 20 | 6 | 2 | 18291621 | |
| Pubmed | Complexes of tetraspanins with integrins: more than meets the eye. | 6.83e-06 | 24 | 6 | 2 | 11739647 | |
| Pubmed | 9.82e-04 | 285 | 6 | 2 | 21423176 | ||
| Pubmed | 6.96e-03 | 772 | 6 | 2 | 16341674 | ||
| Pubmed | 7.71e-03 | 814 | 6 | 2 | 23251661 | ||
| GeneFamily | CD molecules|Tetraspanins | 3.22e-05 | 33 | 5 | 2 | 768 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.25e-04 | 141 | 6 | 2 | M10381 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.56e-04 | 146 | 6 | 2 | MM973 | |
| Coexpression | GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.00e-04 | 153 | 6 | 2 | M9151 | |
| Coexpression | AKT_UP_MTOR_DN.V1_DN | 7.30e-04 | 185 | 6 | 2 | M2664 | |
| Coexpression | AKT_UP.V1_DN | 7.45e-04 | 187 | 6 | 2 | M2666 | |
| Coexpression | GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP | 8.10e-04 | 195 | 6 | 2 | M3319 | |
| Coexpression | GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP | 8.18e-04 | 196 | 6 | 2 | M9707 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 8.18e-04 | 196 | 6 | 2 | M6227 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_UP | 8.18e-04 | 196 | 6 | 2 | M5524 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN | 8.26e-04 | 197 | 6 | 2 | M6219 | |
| Coexpression | GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 8.35e-04 | 198 | 6 | 2 | M6217 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_R848_DC_UP | 8.35e-04 | 198 | 6 | 2 | M4693 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_UP | 8.52e-04 | 200 | 6 | 2 | M8260 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NKTCELL_DN | 8.52e-04 | 200 | 6 | 2 | M4825 | |
| Coexpression | GSE27786_NKCELL_VS_NEUTROPHIL_DN | 8.52e-04 | 200 | 6 | 2 | M4859 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP | 8.52e-04 | 200 | 6 | 2 | M7221 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_UP | 8.52e-04 | 200 | 6 | 2 | M5675 | |
| Coexpression | GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN | 8.52e-04 | 200 | 6 | 2 | M3674 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN | 8.52e-04 | 200 | 6 | 2 | M3219 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP | 8.52e-04 | 200 | 6 | 2 | M4570 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 9.12e-04 | 207 | 6 | 2 | M1963 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 1.06e-03 | 223 | 6 | 2 | MM838 | |
| Coexpression | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP | 1.21e-03 | 239 | 6 | 2 | M4716 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.88e-04 | 456 | 6 | 3 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.91e-04 | 459 | 6 | 3 | GSM777037_500 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 187 | 6 | 3 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 187 | 6 | 3 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.56e-06 | 194 | 6 | 3 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.71e-06 | 200 | 6 | 3 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-06 | 200 | 6 | 3 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.71e-06 | 200 | 6 | 3 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-04 | 164 | 6 | 2 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 164 | 6 | 2 | cf62d34ce9dd220fe61748466c84fd70d9ba697c | |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 164 | 6 | 2 | e00549bc8b3a5566f39031f39d7e698b0b107a7f | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.99e-04 | 165 | 6 | 2 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.99e-04 | 165 | 6 | 2 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 167 | 6 | 2 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 167 | 6 | 2 | 0e746483773bde6582874a33591ab2a578d724eb | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 167 | 6 | 2 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D122|Adult / Lineage, Cell type, age group and donor | 2.06e-04 | 168 | 6 | 2 | 8c3e1e45b422813bcdfa4273b1167db649a312f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 169 | 6 | 2 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 15a9183c838cc6384d7f5dfeae3d30602964c9b3 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 170 | 6 | 2 | b4f2c05db2c2591561fd42febc72eed3b5e8f9fb | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 2.16e-04 | 172 | 6 | 2 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 173 | 6 | 2 | 7dc988fc0ba29990567bf1bcdeb3faeeee507eb1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-04 | 173 | 6 | 2 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | severe_influenza-Plasmablast|severe_influenza / disease group, cell group and cell class (v2) | 2.21e-04 | 174 | 6 | 2 | 8c6c4d794373e774ecb3382cb7163b4246b98780 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.21e-04 | 174 | 6 | 2 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 2.21e-04 | 174 | 6 | 2 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 2.21e-04 | 174 | 6 | 2 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-04 | 175 | 6 | 2 | dc7721794162dee96944f4b4b87b5681bb02ea8f | |
| ToppCell | Influenza_Severe-Plasmablast|World / Disease group and Cell class | 2.23e-04 | 175 | 6 | 2 | 14df8fc6f6beae1be7b7bd5837546d1ac1239a6f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.23e-04 | 175 | 6 | 2 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | Influenza_Severe-Plasmablast|Influenza_Severe / Disease group and Cell class | 2.23e-04 | 175 | 6 | 2 | 3f9b9793d3d1b7a9b97899272b6a0d37b05c11d1 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-04 | 176 | 6 | 2 | 460cb302c5b3d609c65b924e1d4e8ea057a68485 | |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | 2.26e-04 | 176 | 6 | 2 | d895a6b295cd649273ff80ad7785a3e0ae4c728a | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.26e-04 | 176 | 6 | 2 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | 2.26e-04 | 176 | 6 | 2 | 4b4416f342b732d2cc60133838728880326257d8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 2.26e-04 | 176 | 6 | 2 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 177 | 6 | 2 | 3a85aa2bf3f2fdbea57d22d68e022cb3f6c2eb65 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-04 | 177 | 6 | 2 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-04 | 178 | 6 | 2 | 693f1135d9c5545945e80c7ba3d098afc0ccac29 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.31e-04 | 178 | 6 | 2 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.31e-04 | 178 | 6 | 2 | 6765c6970b1f2b719a20d2afd7471e1c262f3fc4 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 178 | 6 | 2 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 179 | 6 | 2 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 179 | 6 | 2 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-04 | 179 | 6 | 2 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-04 | 179 | 6 | 2 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 180 | 6 | 2 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.36e-04 | 180 | 6 | 2 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 181 | 6 | 2 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 182 | 6 | 2 | 82d6f72649c7dd4d64a84a9795edebdef2f285d6 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.42e-04 | 182 | 6 | 2 | 345d0f9d5ee30434bc2aac17608ccdc9e61c8fa3 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-04 | 183 | 6 | 2 | 2d0d3b486498a7903fa9a1f48b189291da49c430 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early|bone_marrow / Manually curated celltypes from each tissue | 2.44e-04 | 183 | 6 | 2 | 3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.44e-04 | 183 | 6 | 2 | 9c66a40c355387f805dbdca4162dd05af5c1d8d4 | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 184 | 6 | 2 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | control-Others-Megakaryocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.47e-04 | 184 | 6 | 2 | 213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d | |
| ToppCell | control-Others|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.47e-04 | 184 | 6 | 2 | a63b39fcc570b554cf10e8e47c2c1e079034768f | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 185 | 6 | 2 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.50e-04 | 185 | 6 | 2 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 185 | 6 | 2 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.50e-04 | 185 | 6 | 2 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.50e-04 | 185 | 6 | 2 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.50e-04 | 185 | 6 | 2 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 185 | 6 | 2 | 0ca99fcbd30c454bcdc2aa5265a0e4dba25666ea | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 185 | 6 | 2 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.50e-04 | 185 | 6 | 2 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 185 | 6 | 2 | 0f722ffcc3e78d5c6b1b79d31d00929801a993f1 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 2.50e-04 | 185 | 6 | 2 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.50e-04 | 185 | 6 | 2 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 185 | 6 | 2 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 185 | 6 | 2 | c985a4b184d382a79aaff07f81c0efede2c2d493 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 185 | 6 | 2 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 185 | 6 | 2 | d0d0e000ebe1fc35a987930ceaf7e3369e0c694c | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.50e-04 | 185 | 6 | 2 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-04 | 186 | 6 | 2 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 186 | 6 | 2 | 744bf39af2fb5a7454477174d7755a6d78cd279f | |
| ToppCell | severe-Others|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.52e-04 | 186 | 6 | 2 | 234a4bc7c3529daf8804f2a366887d02a47075cd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery|Adult / Lineage, Cell type, age group and donor | 2.52e-04 | 186 | 6 | 2 | 2d1c4ea2e401db89971582ee54618a8b0c81b8ac | |
| ToppCell | (4)_Lymph_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.52e-04 | 186 | 6 | 2 | 6b3afc2ae870ff73e30a60ce84fcee0eb365d809 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.55e-04 | 187 | 6 | 2 | 34cad5ac8602fe88ca3d421257190c9a388d4cb0 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-04 | 187 | 6 | 2 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.55e-04 | 187 | 6 | 2 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | severe-Others-Megakaryocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.55e-04 | 187 | 6 | 2 | ef16331d1e5abe6bde7f09793c4a87a6ac24e592 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.55e-04 | 187 | 6 | 2 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 2.55e-04 | 187 | 6 | 2 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.58e-04 | 188 | 6 | 2 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.58e-04 | 188 | 6 | 2 | c00ba0abd0c7bb2c8f9166a2ac6220aae4f4d857 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.58e-04 | 188 | 6 | 2 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-04 | 188 | 6 | 2 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-04 | 188 | 6 | 2 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-04 | 188 | 6 | 2 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-04 | 188 | 6 | 2 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.58e-04 | 188 | 6 | 2 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.58e-04 | 188 | 6 | 2 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | facs-Marrow-KLS|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 189 | 6 | 2 | 4214abfa07b047e256df43e472f9a835a18ed7a3 | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 2.60e-04 | 189 | 6 | 2 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 189 | 6 | 2 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 189 | 6 | 2 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-04 | 189 | 6 | 2 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-04 | 190 | 6 | 2 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l27|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-04 | 190 | 6 | 2 | 632d5dc11765053366d61f0a0c7916111cea4f50 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-04 | 190 | 6 | 2 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 1.29e-05 | 199 | 6 | 3 | 1527_UP | |
| Drug | Nimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A | 9.64e-04 | 185 | 6 | 2 | 3103_UP | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 9.74e-04 | 186 | 6 | 2 | 1533_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.03e-03 | 191 | 6 | 2 | 2190_DN | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.04e-03 | 192 | 6 | 2 | 5013_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 3614_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 4848_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 2767_UP | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 7485_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2707_UP | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 4426_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 5642_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 3637_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 2798_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 6106_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4134_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4158_DN | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4097_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 5252_UP | |
| Drug | Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4708_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4266_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2532_DN | |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 5051_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2229_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 1503_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 5009_UP | |
| Drug | (+) -Levobunolol hydrochloride [47141-41-3]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3355_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3934_DN | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 3622_DN | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 4963_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5246_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5501_DN | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5865_UP | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5515_UP | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 7064_UP | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 3341_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5002_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; HL60; HG-U133A | 1.10e-03 | 198 | 6 | 2 | 1772_UP | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 6767_UP | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5321_DN | |
| Drug | Disopyramide [3737-09-5]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 2408_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 4668_DN | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 7081_UP | |
| Drug | leukotoxin B (12,13-EODE); Down 200; 0.2uM; MCF7; HT_HG-U133A_EA | 1.11e-03 | 199 | 6 | 2 | 1108_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 2933_DN | |
| Drug | Lidoflazine [3416-26-0]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 6278_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5323_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; PC3; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 4592_UP | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5309_DN | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 4740_UP | |
| Drug | Benzathine benzylpenicillin [5928-84-7]; Down 200; 4.2uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 2939_DN | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 4769_UP | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 3105_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 3078_DN | |
| Drug | Theobromine [83-67-0]; Up 200; 22.2uM; PC3; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 6613_UP | |
| Disease | telomere length | 1.64e-03 | 313 | 6 | 2 | EFO_0004505 | |
| Disease | DNA methylation | 6.98e-03 | 656 | 6 | 2 | GO_0006306 | |
| Disease | waist-hip ratio | 2.31e-02 | 1226 | 6 | 2 | EFO_0004343 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLGGWWCHCLYGRQG | 466 | Q5K4E3 | |
| IGAWWGGFLLCGALL | 261 | Q9UIG8 | |
| MGHLWLLGIWGLCGL | 1 | Q86WI1 | |
| WLGGCGVLGVGIWLA | 21 | O14817 | |
| WAICWLLGGLLLHGG | 6 | Q9NS98 | |
| WLCGCGLLGVGIWLS | 21 | O75954 |